Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 15,issue 3  (01-2015)

Period of time： 2015年3期

Publisher： Bentham Science Publishers

Founded in： 2001

Total resources： 51

E-ISSN： 2212-3873|15|3

ISSN： 1871-5303

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 15,issue 3

Menu

Meet Our Editorial Board Member:

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 15,issue 3 , Vol. 15, Iss. 3, 2015-01 , pp. 169-169

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Editorial (Thematic Issue: Anti-inflammatory Treatment for Seemingly Non-inflammatory Disorders-Part 2)

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 15,issue 3 , Vol. 15, Iss. 3, 2015-01 , pp. 170-170

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

One Special Question to Start with: Can HIF/NFkB be a Target in Inflammation?

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 15,issue 3 , Vol. 15, Iss. 3, 2015-01 , pp. 171-185

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Resveratrol Targets in Inflammation

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 15,issue 3 , Vol. 15, Iss. 3, 2015-01 , pp. 186-195

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 15,issue 3 , Vol. 15, Iss. 3, 2015-01 , pp. 196-205

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

IL-1 as a target in inflammation

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 15,issue 3 , Vol. 15, Iss. 3, 2015-01 , pp. 206-211

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Vitamin-mediated immune regulation in the development of inflammatory diseases

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 15,issue 3 , Vol. 15, Iss. 3, 2015-01 , pp. 212-215

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Metalloproteinases: potential therapeutic targets for rheumatoid arthritis

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 15,issue 3 , Vol. 15, Iss. 3, 2015-01 , pp. 216-222

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Beneficial Effects of Vildagliptin on Metabolic Parameters in Patients with Type 2 Diabetes

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 15,issue 3 , Vol. 15, Iss. 3, 2015-01 , pp. 223-228

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Objective Assessment of the Rheological Muscle Property in the Treatment of Fibromyalgia

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders),volume 15,issue 3 , Vol. 15, Iss. 3, 2015-01 , pp. 229-233

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 12 item(s)